Article Text

Download PDFPDF
Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H+/K+-ATPase
  1. W Beila,
  2. K-F Sewinga,
  3. R Buschec,
  4. S Wagnerb
  1. aDepartment of General Pharmacology, Hannover Medical School, Hannover, Germany, bDepartment of Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany, cDepartment of Physiology, School of Veterinary Medicine, Hannover, Germany
  1. Dr W Beil, Department of General Pharmacology, Medizinische Hochschule Hannover, Carl-Neuberg-Straβe 1, D-30625 Hannover, Germany. Beil.Winfried@MH- Hannover.de

Abstract

BACKGROUND In duodenal ulcer patients, intragastric acidity during omeprazole treatment is significantly lower before Helicobacter pylori eradication than after cure.

AIMS To determine ifH pylori enhances the acid inhibitory potency of omeprazole in isolated parietal cells and on H+/K+-ATPase.

METHODS Rat parietal cells and pig gastric membrane vesicles enriched in H+/K+-ATPase activity were incubated withH pylori and the H pylori fatty acid cis9,10-methyleneoctadecanoic acid (MOA), and the inhibitory effects of omeprazole on parietal cell acid production, H+/K+-ATPase enzyme activity, and ATPase mediated proton transport were assessed.

RESULTS In isolated parietal cells, H pylori and MOA increased the acid inhibitory potency of omeprazole 1.8 fold.H pylori did not affect the inhibitory potency of omeprazole on H+/K+-ATPase enzyme activity. In proton transport studies, H pylori (intact bacteria and sonicate) and MOA accelerated the onset of the inhibitory effect of omeprazole and enhanced the proton dissipation rate in response to omeprazole. H pylori itself increased proton permeability at the vesicle membrane.

CONCLUSION Our results show that H pylori augments the acid inhibitory potency of omeprazole in parietal cells and enhances omeprazole induced proton efflux rate from gastric membrane vesicles. We suggest that omeprazole unmasks the permanent effect ofH pylori on proton permeability at the apical parietal cell membrane, which is counteracted in the absence of a proton pump inhibitor by a reserve H+/K+-ATPase capacity.

  • H pylori
  • parietal cells
  • omeprazole
  • H+/K+-ATPase
  • Abbreviations used in this paper

    ATP
    adenosine 5′-triphosphate
    EDTA
    ethylenediaminetetraacetic acid
    MOA
    cis9,10-methyleneoctadecanoic acid
    dbcAMP
    dibuturyl cyclic adenosine monophosphate
  • Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Abbreviations used in this paper

    ATP
    adenosine 5′-triphosphate
    EDTA
    ethylenediaminetetraacetic acid
    MOA
    cis9,10-methyleneoctadecanoic acid
    dbcAMP
    dibuturyl cyclic adenosine monophosphate
  • View Full Text